Every time through the AI newsletter, investors ask questions on the investor interactive platform: Now that new African virus strains are threatening to infect the world, I would like to ask whether the products produced by your company can also detect new virus strains?
Jiu’an Medical(002432.SZ) stated on the investor interaction platform on November 29 that for the new type of coronavirus “Omicron” mutant strains currently found in South Africa, the company passed the currently available literature and compared bioinformatics with new mutations. Strain B.1.1.529: There are about 50 mutation sites, of which 32 are on the S protein (the protein recognized by the vaccine), and the N protein has 4 mutation sites, including 3 mutation sites in the last year Already appeared. Most of the antigen detection kit products, including our products, are for the detection of N protein. From the analysis of the comparison of bioinformatics, it is possible to test new mutant strains, but these products must pass the test performance After the experimental verification, the effectiveness of the product for detecting the virus strain can be confirmed.
(Source: Daily Economic News)
Article source: Daily Economic News
Editor in charge: 6
Original title: Jiu’an Medical: Antigen detection kit products are likely to test new mutant strains
Solemnly declare: The purpose of this information released by Oriental Fortune.com is to spread more information and has nothing to do with this stand.
Scan the QR code to follow
Oriental Wealth Official Website WeChat